» Articles » PMID: 21075858

Plakoglobin Rescues Adhesive Defects Induced by Ectodomain Truncation of the Desmosomal Cadherin Desmoglein 1: Implications for Exfoliative Toxin-mediated Skin Blistering

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2010 Nov 16
PMID 21075858
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Desmoglein 1 (Dsg1) is a desmosomal cadherin that is essential to epidermal integrity. In the blistering diseases bullous impetigo and staphylococcal scalded-skin syndrome, pathogenesis depends on cleavage of Dsg1 by a bacterial protease, exfoliative toxin A, which removes residues 1 to 381 of the Dsg1 ectodomain. However, the cellular responses to Dsg1 cleavage that precipitate keratinocyte separation to induce blister formation are unknown. Here, we show that ectodomain-deleted Dsg1 (Δ381-Dsg1) mimics the toxin-cleaved cadherin, disrupts desmosomes, and reduces the mechanical integrity of keratinocyte sheets. In addition, we demonstrate that truncated Dsg1 remains associated with its catenin partner, plakoglobin, and causes a reduction in the levels of endogenous desmosomal cadherins in a dose-dependent manner, leading us to hypothesize that plakoglobin sequestration by truncated Dsg1 destabilizes other cadherins. Accordingly, a triple-point mutant of the ectodomain-deleted cadherin, which is uncoupled from plakoglobin, does not impair adhesion, indicating that this interaction is essential to the pathogenic potential of truncated Dsg1. Moreover, we demonstrate that increasing plakoglobin levels rescues cadherin expression, desmosome organization, and functional adhesion in cells expressing Δ381-Dsg1 or treated with exfoliative toxin A. Finally, we report that histone deacetylase inhibition up-regulates desmosomal cadherins and prevents the loss of adhesion induced by Dsg1 truncation. These findings further our understanding of the mechanism of exfoliative toxin-induced pathology and suggest novel strategies to suppress blistering in bulbous impetigo and staphylococcal scalded-skin syndrome.

Citing Articles

Understanding host's response to staphylococcal scalded skin syndrome.

Rouva G, Vergadi E, Krasagakis K, Galanakis E Acta Paediatr. 2024; 114(2):241-247.

PMID: 39411997 PMC: 11706759. DOI: 10.1111/apa.17462.


ERK hyperactivation in epidermal keratinocytes impairs intercellular adhesion and drives Grover disease pathology.

Simpson C, Tiwaa A, Zaver S, Johnson C, Chu E, Harms P JCI Insight. 2024; 9(21).

PMID: 39325541 PMC: 11601706. DOI: 10.1172/jci.insight.182983.


Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease.

Zaver S, Sarkar M, Egolf S, Zou J, Tiwaa A, Capell B JCI Insight. 2023; 8(18).

PMID: 37561594 PMC: 10561730. DOI: 10.1172/jci.insight.170739.


Damaged Keratin Filament Network Caused by Mutations in Localized Recessive Epidermolysis Bullosa Simplex.

Chen F, Yao L, Zhang X, Gu Y, Yu H, Yao Z Front Genet. 2021; 12:736610.

PMID: 34912369 PMC: 8667171. DOI: 10.3389/fgene.2021.736610.


Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor.

Uberoi A, Bartow-McKenney C, Zheng Q, Flowers L, Campbell A, Knight S Cell Host Microbe. 2021; 29(8):1235-1248.e8.

PMID: 34214492 PMC: 8364505. DOI: 10.1016/j.chom.2021.05.011.


References
1.
Johnston G . Treatment of bullous impetigo and the staphylococcal scalded skin syndrome in infants. Expert Rev Anti Infect Ther. 2004; 2(3):439-46. DOI: 10.1586/14787210.2.3.439. View

2.
Kopp T, Sitaru C, Pieczkowski F, Schneeberger A, Fodinger D, Zillikens D . IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient. J Dtsch Dermatol Ges. 2006; 4(12):1045-50. DOI: 10.1111/j.1610-0387.2006.06166.x. View

3.
Rickman L, Simrak D, Stevens H, Hunt D, King I, Bryant S . N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet. 1999; 8(6):971-6. DOI: 10.1093/hmg/8.6.971. View

4.
Cheng X, Koch P . In vivo function of desmosomes. J Dermatol. 2004; 31(3):171-87. DOI: 10.1111/j.1346-8138.2004.tb00654.x. View

5.
Kitajima Y, Aoyama Y . A perspective of pemphigus from bedside and laboratory-bench. Clin Rev Allergy Immunol. 2007; 33(1-2):57-66. DOI: 10.1007/s12016-007-0036-5. View